MedTrace Logo

"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"

NCT01694433 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2019-05-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to study the effects of topical Vitamin D cream (Calcipotriene, also known as Dovonex) on acne. The information gained from this study may lead to new treatments for acne. In this study, Calcipotriene will be compared with a placebo, a cream that looks like Calcipotriene, but contains no active ingredients.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Calcipotriene

1g daily BID

DRUG

Placebo

1g daily BID

Sponsors & Collaborators

Principal Investigators

  • Jenny Kim, MD,PhD · UCLA Department of Medicine/Division of Dermatology and Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-01-09
Completion
2014-01-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01694433 on ClinicalTrials.gov